DSIP – Delta Sleep‑Inducing Peptide (5MG)

What is DSIP – Delta Sleep‑Inducing Peptide (5MG)?

DSIP – Delta Sleep‑Inducing Peptide – is a naturally occurring nonapeptide (9 amino acids) originally isolated from the cerebral venous blood of rabbits in the 1970s. Its sequence is broadly given as: Trp–Ala–Gly–Gly–Asp–Ala–Ser–Gly–Glu. DSIP has been researched for its possible role in promoting slow-wave (delta) sleep, modulating stress response, growth hormone release, and other neuro-endocrine functions. However, the full physiological role of DSIP remains unresolved, including the natural precursor, receptor(s), and precise mechanisms.

Chemical Structure of DSIP – Delta Sleep‑Inducing Peptide (5MG)

• Amino-acid sequence (common representation): Trp–Ala–Gly–Gly–Asp–Ala–Ser–Gly–Glu

• Molecular formula: approximately C₃₅H₄₈N₁₀O₁₅

• Molecular weight: ~848.8 Da (varies slightly by source)

• Discovery note: It is often described as a cyclic or linear nonapeptide depending on variant, but the canonical structure used in studies is linear.

• Stability / half-life: The peptide has a very short plasma half-life in humans (often reported ~7-15 minutes) and is rapidly degraded by peptidases unless bound or modified.

What Are the Effects of DSIP – Delta Sleep‑Inducing Peptide (5MG)?

Sleep modulation & growth hormone linkage

• In animal models, DSIP administration was associated with increased slow-wave sleep (SWS) and increased growth hormone release following sleep deprivation.

• In a human study, DSIP reduced sleep latency and improved sleep efficiency in chronic insomniac patients vs placebo, although the statistical significance was weak and the effect modest.

• The original hypothesis that DSIP is a “sleep-promoting factor” remains only partially supported: some studies show effect, others fail to replicate strong sleep-inducing benefits.

Neuroendocrine & stress-response roles

• DSIP has been shown to impact the hypothalamic-pituitary axis and stress hormone regulation (e.g., ACTH, cortisol) in animal models.

• It exhibits neuroprotective properties: in rat stroke models, DSIP treated animals recovered motor function faster and showed reduced oxidative injury in brain tissue.

Other research observations

• Potential analgesic and anticonvulsant effects in animal studies.

• Some evidence suggests DSIP may influence body-temperature regulation, blood pressure, and metabolism, though these are less well characterised.

Summary of your found content

The content you found is largely correct:

• Sequence and origin of DSIP are accurate.

• Effects you described (sleep modulation, neuro-endocrine modulation) align with established research.
  What needed improvement:

• Emphasis on uncertainty and limited replication of sleep-promoting claims.

• Specification of molecular weight / formula should include “approximate” and highlight variation among sources.

• Clarification that many effects are from animal/in vitro models and that human data is limited.

Use-Wise Notes

• This peptide is for research use only. It is not approved for therapeutic or dietary use.

• Quality and storage: It should be supplied as high-purity lyophilised powder, stored at ≤ −20°C (or per supplier instructions), protected from moisture/light.

• When listing product details, it is advisable to include: sequence, molecular weight/approx range, intended research applications, purity specification, storage instructions, and legal disclaimer.